Highlights
ASX: OPT       OPTHEA LIMITED
Last Price Today's Change   Day's Range   Trading Volume
3.53   -0.05 (1.40%)  3.35 - 3.64  298,504

Overview

 
Avg Volume (4 weeks):1,569,348
4 Weeks Range:3.16 - 3.88
4 Weeks Price Volatility (%):
51.39%
52 Weeks Range:0.53 - 4.15
52 Weeks Price Volatility (%):
82.87%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Opthea Limited, formerly Circadian Technologies Limited, is engaged in developing and commercializing therapies primarily for eye diseases. The Company operates in medical technology and healthcare industry in Australia. The Company is involved in the development activities, which are based on the intellectual property portfolio covering key targets, such as vascular endothelial growth factors [VEGF]-C, -D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, including angiogenesis and lymph angiogenesis respectively, as well as vascular leakage. It is developing its lead molecule, which is a soluble form of VEGFR-3 referred to as OPT-302, for the treatment of wet age-related macular degeneration (wet AMD). OPT-302 blocks two members of the vascular endothelial growth factor family, VEGF-C and VEGF-D, which cause blood vessels to grow and leak. It is investigating OPT-302 in an ongoing Phase I/IIA clinical trial in wet AMD patients.

  Be the first to like this.
 


 

495  563  877  2440 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 OVL 0.013+0.003 
 MLX 0.22+0.035 
 BLK 0.0120.00 
 RIM 0.003-0.001 
 SCG 3.84-0.01 
 AUZ 0.0290.00 
 RMX 0.006+0.001 
 BD1 0.0520.00 
 ISX 1.070.00 
 BCB 0.06+0.001 
Partners & Brokers